Creatine Monohydrate Versus Creatine Hydrochloride on Strength and Body Composition in Elite Team-Sport Athletes
CrM_CrHCl
1 other identifier
interventional
48
1 country
1
Brief Summary
A triple-arm double-blinded placebo-controlled repeated-measures randomized clinical trial in Colombian elite team-sport athletes. The aim is to evaluate the effects on strength-related parameters and body composition after eight weeks of supplementation with creatine monohydrate (CrM) and creatine hydrochloride (Cr-HCl). The study will be reported following the Consolidated Standards of Reporting Trials (CONSORT) extension to Multi-Arm Parallel-Group Randomized Trials. All variables will be measured at baseline and after eight weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2022
CompletedFirst Submitted
Initial submission to the registry
December 31, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedJanuary 26, 2023
January 1, 2023
9 months
December 31, 2022
January 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Lower-limb muscle power
Countermovement and drop jump will be performed on contact mat (height in centimeters and time of flight in seconds)
Eight weeks
Neuromuscular strength
The load-velocity profile in squat and bench press exercises will be obtained with a linear position transducer (load in kilograms versus mean propulsive velocity in meters per second).
Eight weeks
Upper-limb muscle strength
Maximal shoulder external and internal strength will be measure with a isokinetic dynamometer.
Eight weeks
Secondary Outcomes (1)
Body composition
Eight weeks
Study Arms (3)
Creatine monohydrate
ACTIVE COMPARATOR5 g of creatine monohydrate per day for eight weeks
Creatine hydrochloride
EXPERIMENTAL5 g of creatine hydrochloride per day for eight weeks
Placebo
PLACEBO COMPARATOR5 g of maltodextrin per day for eight weeks
Interventions
The CrM group supplemented the diet with five grams of micronized creatine monohydrate per day for eight weeks. The CrM supplement was fully dissolved in ≈500 mL of water and drank immediately after each training session (in the morning on non-training days).
A placebo group intakes five grams of maltodextrin daily throughout the study. The placebo supplement was fully dissolved in ≈500 mL of water and drank immediately after each training session (in the morning on non-training days).
The Cr-HCl group supplemented the diet with five grams of micronized creatine monohydrate per day for eight weeks. The Cr-HCl supplement was fully dissolved in ≈500 mL of water and drank immediately after each training session (in the morning on non-training days).
Eligibility Criteria
You may qualify if:
- Practicing team sports at the competitive level (handball and softball)
- Having at least one year of competitive sports training experience (including strength training at least three times a week),
- Being attended at INDEPORTES Antioquia.
You may not qualify if:
- Those who do not wish to participate voluntarily (do not sign informed consent),
- Those who were taking nutritional supplements (including creatine) eight weeks prior to the start of the study,
- Those who had a diagnosed pathology or health issues.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dynamical Business and Science Society - DBSS International SASlead
- INDEPORTES Antioquiacollaborator
- CES Universitycollaborator
Study Sites (1)
INDEPORTES Antioquia
Medellín, Antioquia, 050034, Colombia
Related Publications (3)
Kreider RB, Jager R, Purpura M. Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review. Nutrients. 2022 Feb 28;14(5):1035. doi: 10.3390/nu14051035.
PMID: 35268011BACKGROUNDBonilla DA, Kreider RB, Stout JR, Forero DA, Kerksick CM, Roberts MD, Rawson ES. Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review. Nutrients. 2021 Apr 9;13(4):1238. doi: 10.3390/nu13041238.
PMID: 33918657BACKGROUNDJuszczak E, Altman DG, Hopewell S, Schulz K. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement. JAMA. 2019 Apr 23;321(16):1610-1620. doi: 10.1001/jama.2019.3087.
PMID: 31012939BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andres Rojas-Jaramillo, PhD
INDEPORTES Antioquia
- STUDY CHAIR
Diego A Bonilla, PhD
DBSS International SAS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- This was a double-blinded clinical trial since participants and those assessing the outcomes were blinded to the intervention. All groups were given small metallic plastic bags with five grams of powder identical in size, shape, and color but the placebo contained maltodextrin (Tecnas S.A., Medellín, Colombia).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 31, 2022
First Posted
January 26, 2023
Study Start
June 1, 2021
Primary Completion
February 15, 2022
Study Completion
August 22, 2022
Last Updated
January 26, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share